Amalgamated Bank lowered its stake in shares of MetLife, Inc. (NYSE:MET – Free Report) by 3.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 115,870 shares of the financial services provider’s stock after selling 4,088 shares during the quarter. Amalgamated Bank’s holdings in MetLife were worth $9,557,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. National Bank of Canada FI boosted its holdings in MetLife by 54.9% during the first quarter. National Bank of Canada FI now owns 371,062 shares of the financial services provider’s stock worth $26,983,000 after purchasing an additional 131,538 shares during the last quarter. PFG Investments LLC grew its holdings in shares of MetLife by 8.9% in the third quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock valued at $525,000 after acquiring an additional 520 shares in the last quarter. Acadian Asset Management LLC purchased a new stake in shares of MetLife during the first quarter valued at approximately $1,053,000. Entropy Technologies LP lifted its holdings in MetLife by 38.3% during the first quarter. Entropy Technologies LP now owns 30,473 shares of the financial services provider’s stock worth $2,258,000 after acquiring an additional 8,440 shares during the period. Finally, M&G Plc purchased a new position in MetLife in the second quarter worth $2,346,000. 89.81% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on the company. Jefferies Financial Group lifted their target price on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, September 27th. Morgan Stanley dropped their target price on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Wells Fargo & Company lifted their price target on shares of MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a report on Tuesday. Piper Sandler increased their price objective on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a report on Wednesday, October 2nd. Finally, Bank of America lowered their target price on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, MetLife has a consensus rating of “Moderate Buy” and a consensus price target of $88.46.
MetLife Trading Up 0.2 %
Shares of MetLife stock opened at $78.15 on Wednesday. The company’s 50-day moving average price is $80.73 and its 200-day moving average price is $75.03. The company has a market cap of $54.73 billion, a price-to-earnings ratio of 15.76, a PEG ratio of 0.71 and a beta of 1.05. MetLife, Inc. has a 12-month low of $58.89 and a 12-month high of $86.94. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.49.
MetLife Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.79%. MetLife’s dividend payout ratio (DPR) is presently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- What is a Bond Market Holiday? How to Invest and Trade
- Palantir Cracks $50, Is There Still Time to Get on Board?
- How to Choose Top Rated Stocks
- Insider Buying Signals Upside for These 3 Stocks
- Consumer Staples Stocks, Explained
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.